PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 22, 2026PLoS Pathogens0 citationsOpen Access

The crosstalk between acute hepatopancreatic necrosis disease (AHPND) and the Vibrio quorum sensing (QS) system: A review

View Full Paper
HWHao-Ching WangRKRamya KumarMAMichael Eniola Ayenero

Key Points

  • This review aims to explore the interaction between acute hepatopancreatic necrosis disease (AHPND) and the Vibrio quorum sensing (QS) system in shrimp.
  • Review of literature on AHPND and Vibrio species
  • Analysis of the role of quorum sensing in virulence and biofilm formation
  • Discussion on control strategies targeting the QS system, including probiotics and natural products
  • AHPND is caused by Vibrio parahaemolyticus, leading to significant shrimp mortality.
  • Vibrio quorum sensing impacts growth and virulence, regulating important toxins.
  • Potential control strategies include QS inhibitors and probiotics to enhance shrimp health.

Abstract

Acute hepatopancreatic necrosis disease (AHPND) is a disease that has caused significant losses to shrimp farming since 2009. The primary mechanism of this disease involves the binary toxins PirA vp and PirB vp , which are produced by specific strains of Vibrio parahaemolyticus , and which lead to significant damage to the hepatopancreatic cells of shrimps. Recent studies on the pathology of AHPND have also highlighted the role of the Vibrio quorum sensing (QS) system, which affects growth, virulence, and biofilm regulation in Vibrio species. For example, deletion of the qseC gene reduces the virulence of the AHPND-causative V. parahaemolyticus . Most importantly, the QS regulators LuxO vp and AphB vp have been implicated as they control the growth-phase-dependent expression of the pirA vp /pirB vp genes. Additionally, given the growing problem of antibiotic resistance, this article reviews several alternative control strategies targeting the QS system, including QS inhibition using natural products, biofloc technology, and the development of small-molecule inhibitors against AphB vp . Finally, we also discussed the potential of using probiotics to enhance shrimp disease resistance through QS inhibition, highlighting the feasibility of targeting the QS system for AHPND control.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/699a9e20482488d673cd4975https://doi.org/10.1371/journal.ppat.1013980
Ask AI
Helpful
Bookmark
Share
View Full Paper